Landscapes / Companies
Luminary Therapeutics not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 3 in all
Trials
4 active
6 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | Dec 2030Phase 2 trial completes | |||
| Next date | Dec 2030 · Phase 2 trial completes | ||||
| Also tested for | Systemic Lupus Erythematosus, Non-Hodgkin Lymphoma Refractory/ Relapsed and 7 more | ||||
| Open drug page | |||||
— |
Phase 1 | Apr 2029Phase 1 trial completes | |||
| Next date | Apr 2029 · Phase 1 trial completes | ||||
| Also tested for | Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia and 6 more | ||||
| Open drug page | |||||
About
- No active trial
- Autologous CAR-T cell therapy expressing the BAFF-ligand.
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021